MentionFox
Home › Layoffs › Vir Biotechnology, Inc.
SEC filings · Form 8-K, Item 2.05

Vir Biotechnology, Inc. layoffs and restructuring

Before you join, sell to or invest in Vir Biotechnology, Inc.

MentionFox check on Vir Biotechnology, Inc.: only 2 sources on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/vir-biotechnology

  • Note: Layoff plan disclosed Aug 2024 (about 140 employees) (filing)

New since last check: Layoff plan disclosed Aug 2024 (about 140 employees) (filing, first seen 14 November 2026).

Check Vir Biotechnology, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Vir Biotechnology, Inc.?

Every exit or restructuring plan Vir Biotechnology, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

About 140 employees are affected, about 25% of its workforce, according to Vir Biotechnology, Inc.'s latest layoff filing, on August 1, 2024. As of November 15, 2026, Vir Biotechnology, Inc. has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, August 1, 2024).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

ARCH Venture Fund IX, L.P. also filed stake reports on 2 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Vir Biotechnology, Inc.

Free to see. No signup.

People from Vir Biotechnology, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Vir Biotechnology, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest, employees140
Latest filing2024-08-01

Vir Biotechnology, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Vir Biotechnology have layoffs in 2024? What its filings say

Vir Biotechnology, Inc. (CIK 1706431) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2024-08-01

Employees affected

Impacted employees represent approximately 25% of the Company's workforce, or approximately 140 employees.

Expected charges

As a result of these changes, the Company expects to incur restructuring charges between $11 million to $13 million, primarily related to employee severance cash expenditures.

Also on the record for Vir Biotechnology, Inc.

DateRecordFigureOur pageSource
November 10, 2026Stake report, Schedule 13G, by STATE STREET CORPORATION4.6% of the class5%+ stakesSource
November 6, 2026Stake report, Schedule 13D/A, by ARCH Venture Fund IX, L.P.7.3% of the class5%+ stakesSource
October 28, 2026Leadership change: Suzanne Topalian appointed, Director—Leadership changesSource
October 27, 2026Stake report, Schedule 13G/A, by BlackRock, Inc.12.4% of the class5%+ stakesSource
October 1, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
August 7, 2026Stake report, Schedule 13G, by STATE STREET CORPORATION5.9% of the class5%+ stakesSource
July 31, 2026Stake report, Schedule 13G/A, by Vanguard Portfolio Management6.85% of the class5%+ stakesSource
July 24, 2026Leadership change: Brent Sabatini appointed, Chief Accounting Officer—Leadership changesSource
June 10, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
May 28, 2026Leadership change: Saira Ramasastry departs, Director—Leadership changesSource
May 15, 2026Stake report, Schedule 13G/A, by SB Investment Advisers (UK) Limited6.5% of the class5%+ stakesSource
April 29, 2026Stake report, Schedule 13G, by Vanguard Portfolio Management5.79% of the class5%+ stakesSource

Keep reading

More on Vir Biotechnology, Inc. and the records around it.

Vir Biotechnology, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Vir Biotechnology, Inc.?

Want the whole picture on Vir Biotechnology, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Vir Biotechnology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Vir Biotechnology, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 17 records.

Tools for this story

Each opens in a new tab, filled in for Vir Biotechnology, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/vir-biotechnology
Last updated 2026-11-15
Vir Biotechnology, Inc. layoffs 2024: about 140 jobs (8-K). MentionFox, 2026-11-15. https://mentionfox.com/layoffs/vir-biotechnology